These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 10692462)

  • 21. Platelet-derived growth factor stimulation of mitogen-activated protein kinases and cyclin D1 promoter activity in cultured airway smooth-muscle cells. Role of Ras.
    Page K; Li J; Hershenson MB
    Am J Respir Cell Mol Biol; 1999 Jun; 20(6):1294-302. PubMed ID: 10340949
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of an isoform of the novel signal transduction protein ST5 is linked to cell morphology.
    Hubbs AE; Majidi M; Lichy JH
    Oncogene; 1999 Apr; 18(15):2519-25. PubMed ID: 10229203
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Docosahexaenoic acid modulates phorbol ester-induced activation of extracellular signal-regulated kinases 1 and 2 in NIH/3T3 cells.
    Denys A; Hichami A; Maume B; Khan NA
    Lipids; 2001 Aug; 36(8):813-8. PubMed ID: 11592732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. SCH 51344 inhibits ras transformation by a novel mechanism.
    Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
    Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Lipopolysaccharide signals activation of tumor necrosis factor biosynthesis through the ras/raf-1/MEK/MAPK pathway.
    Geppert TD; Whitehurst CE; Thompson P; Beutler B
    Mol Med; 1994 Nov; 1(1):93-103. PubMed ID: 8790605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. R-Ras3, a brain-specific Ras-related protein, activates Akt and promotes cell survival in PC12 cells.
    Kimmelman AC; Osada M; Chan AM
    Oncogene; 2000 Apr; 19(16):2014-22. PubMed ID: 10803462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential activation of protein kinase B and p70(S6)K by glucose and insulin-like growth factor 1 in pancreatic beta-cells (INS-1).
    Dickson LM; Lingohr MK; McCuaig J; Hugl SR; Snow L; Kahn BB; Myers MG; Rhodes CJ
    J Biol Chem; 2001 Jun; 276(24):21110-20. PubMed ID: 11274216
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation.
    Tognon C; Garnett M; Kenward E; Kay R; Morrison K; Sorensen PH
    Cancer Res; 2001 Dec; 61(24):8909-16. PubMed ID: 11751416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Malolactomycin D, a potent inhibitor of transcription controlled by the Ras responsive element, inhibits Ras-mediated transformation activity with suppression of MMP-1 and MMP-9 in NIH3T3 cells.
    Futamura M; Kamiya S; Tsukamoto M; Hirano A; Monden Y; Arakawa H; Nishimura S
    Oncogene; 2001 Oct; 20(46):6724-30. PubMed ID: 11709707
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mitogen-activated protein kinase (MAPK)-docking sites in MAPK kinases function as tethers that are crucial for MAPK regulation in vivo.
    Grewal S; Molina DM; Bardwell L
    Cell Signal; 2006 Jan; 18(1):123-34. PubMed ID: 15979847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biochemical and biological functions of the N-terminal, noncatalytic domain of extracellular signal-regulated kinase 2.
    Eblen ST; Catling AD; Assanah MC; Weber MJ
    Mol Cell Biol; 2001 Jan; 21(1):249-59. PubMed ID: 11113199
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Noonan syndrome-associated SHP2/PTPN11 mutants cause EGF-dependent prolonged GAB1 binding and sustained ERK2/MAPK1 activation.
    Fragale A; Tartaglia M; Wu J; Gelb BD
    Hum Mutat; 2004 Mar; 23(3):267-77. PubMed ID: 14974085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activation of Stat1 and subsequent transcription of inducible nitric oxide synthase gene in C6 glioma cells is independent of interferon-gamma-induced MAPK activation that is mediated by p21ras.
    Nishiya T; Uehara T; Edamatsu H; Kaziro Y; Itoh H; Nomura Y
    FEBS Lett; 1997 May; 408(1):33-8. PubMed ID: 9180263
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A dominant role for the c-Jun NH2-terminal kinase in oncogenic ras-induced morphologic transformation of human lung carcinoma cells.
    Xiao L; Lang W
    Cancer Res; 2000 Jan; 60(2):400-8. PubMed ID: 10667594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
    Fukazawa H; Noguchi K; Murakami Y; Uehara Y
    Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A constitutively active and nuclear form of the MAP kinase ERK2 is sufficient for neurite outgrowth and cell transformation.
    Robinson MJ; Stippec SA; Goldsmith E; White MA; Cobb MH
    Curr Biol; 1998 Oct; 8(21):1141-50. PubMed ID: 9799732
    [TBL] [Abstract][Full Text] [Related]  

  • 37. K-ras codon 12 mutation induces higher level of resistance to apoptosis and predisposition to anchorage-independent growth than codon 13 mutation or proto-oncogene overexpression.
    Guerrero S; Casanova I; Farré L; Mazo A; Capellà G; Mangues R
    Cancer Res; 2000 Dec; 60(23):6750-6. PubMed ID: 11118062
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vinexin beta regulates the anchorage dependence of ERK2 activation stimulated by epidermal growth factor.
    Suwa A; Mitsushima M; Ito T; Akamatsu M; Ueda K; Amachi T; Kioka N
    J Biol Chem; 2002 Apr; 277(15):13053-8. PubMed ID: 11825889
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The kinase suppressor of Ras (KSR) modulates growth factor and Ras signaling by uncoupling Elk-1 phosphorylation from MAP kinase activation.
    Sugimoto T; Stewart S; Han M; Guan KL
    EMBO J; 1998 Mar; 17(6):1717-27. PubMed ID: 9501093
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGFbeta1 represses proliferation of pancreatic carcinoma cells which correlates with Smad4-independent inhibition of ERK activation.
    Giehl K; Seidel B; Gierschik P; Adler G; Menke A
    Oncogene; 2000 Sep; 19(39):4531-41. PubMed ID: 11002426
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.